Factors independently associated with steatosis improvement after antiviral therapy in the multivariate analysis
| OR | 95% CI | p Value | |
|---|---|---|---|
| BMI, body mass index; HCV, hepatitis C virus; OR, odds ratio. | |||
| BMI (kg/m2) | |||
| <25 | 1 | ||
| >25 | 0.24 | 0.08–0.73 | 0.02 |
| HCV genotype | |||
| Non-3 | 1 | ||
| 3 | 2.90 | 0.85–10.0 | 0.07 |
| Steatosis grade at time of the first biopsy | |||
| Mild (<10% of hepatocytes) | 1 | ||
| Moderate (10–30% of hepatocytes) | 4.28 | 1.31–14.0 | 0.02 |
| Severe (>30% of hepatocytes) | 5.50 | 1.54–19.6 | 0.01 |
| Response to antiviral therapy | |||
| Absence of response | 1 | ||
| Sustained virological response | 6.06 | 1.61–22.9 | 0.01 |